Abstract:Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by challenges in social communication, repetitive behaviors, and restricted interests. Recent research has emphasized the importance of metabolic dysfunctions in the pathophysiology of ASD. This study investigates metabolic alterations associated with ASD by analyzing transcriptomic data obtained from the prefrontal cortex (bulk tissue and single-nucleus) and data from peripheral blood mononuclear cells (PBMC). We assessed the metabolic activity of each patient based on gene expression profiles, revealing significant downregulation of vital metabolic pathways, including glycolysis, the tricarboxylic acid (TCA) cycle, and oxidative phosphorylation, indicative of hypometabolism. Our analysis also highlighted dysregulation in lipid, vitamin, amino acid, and heme metabolism, which may contribute to the neurodevelopmental delays associated with ASD. Cell-specific metabolic activities in the ASD brain showed altered pathways in astrocytes, oligodendrocytes, excitatory neurons, and interneurons. Furthermore, we identified critical metabolic pathways and genes from PBMC gene expression data that distinguish ASD patients from typically developing individuals. Our findings demonstrate a consistent pattern of metabolic dysfunction across brain and blood samples. This research provides a comprehensive understanding of metabolic alterations in ASD, paving the way for exploring potential therapeutic strategies targeting metabolic dysregulation.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the specific mechanism of metabolic dysfunction in Autism Spectrum Disorder (ASD) and its relationship with neurodevelopmental delay. Specifically, the study explored the metabolic changes in ASD patients by analyzing transcriptome data from the prefrontal cortex (including whole tissues and monocytes) and Peripheral Blood Mononuclear Cells (PBMC). The study aims to reveal the down - regulation of key metabolic pathways in ASD patients, especially the significant decline in glycolysis, the tricarboxylic acid cycle (TCA cycle) and oxidative phosphorylation, as well as the dysregulation of other metabolic pathways such as lipid, vitamin, amino acid and heme metabolism. In addition, the study also analyzed the specific metabolic activities in different cell types (such as astrocytes, oligodendrocytes, excitatory neurons and inhibitory neurons), and how these changes affect neurodevelopment. Finally, through the analysis of blood samples, the study identified key metabolic genes and pathways that may serve as diagnostic markers for ASD, providing a basis for the development of treatment strategies for metabolic dysfunction.

Hypometabolism in Autism Spectrum Disorder: Insights from Brain and Blood Transcriptomics